These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 11158189)

  • 21. Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study.
    Sipos B; Weber D; Ungefroren H; Kalthoff H; Zühlsdorff A; Luther C; Török V; Klöppel G
    Int J Cancer; 2002 Dec; 102(6):592-600. PubMed ID: 12448000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells.
    Zhang HT; Craft P; Scott PA; Ziche M; Weich HA; Harris AL; Bicknell R
    J Natl Cancer Inst; 1995 Feb; 87(3):213-9. PubMed ID: 7535859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.
    Shimamura M; Nagasawa H; Ashino H; Yamamoto Y; Hazato T; Uto Y; Hori H; Inayama S
    Br J Cancer; 2003 Jan; 88(2):307-13. PubMed ID: 12610518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenylbutyrate attenuates the expression of Bcl-X(L), DNA-PK, caveolin-1, and VEGF in prostate cancer cells.
    Goh M; Chen F; Paulsen MT; Yeager AM; Dyer ES; Ljungman M
    Neoplasia; 2001; 3(4):331-8. PubMed ID: 11571633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenesis in bladder cancer--prognostic marker and target for future therapy.
    Streeter EH; Harris AL
    Surg Oncol; 2002 Jun; 11(1-2):85-100. PubMed ID: 12031871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
    Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
    Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression.
    Dozmorov MG; Azzarello JT; Wren JD; Fung KM; Yang Q; Davis JS; Hurst RE; Culkin DJ; Penning TM; Lin HK
    BMC Cancer; 2010 Dec; 10():672. PubMed ID: 21134280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.
    Keledjian K; Kyprianou N
    J Urol; 2003 Mar; 169(3):1150-6. PubMed ID: 12576871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostatic angiogenic responses in late life: antiangiogenic therapy influences and relation with the glandular microenvironment in the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Montico F; Kido LA; Hetzl AC; Cagnon VH
    Prostate; 2015 Apr; 75(5):484-99. PubMed ID: 25521760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts.
    Oku T; Tjuvajev JG; Miyagawa T; Sasajima T; Joshi A; Joshi R; Finn R; Claffey KP; Blasberg RG
    Cancer Res; 1998 Sep; 58(18):4185-92. PubMed ID: 9751633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of hypoxia and p53 in the regulation of angiogenesis in bladder cancer.
    Reiher FK; Ivanovich M; Huang H; Smith ND; Bouck NP; Campbell SC
    J Urol; 2001 Jun; 165(6 Pt 1):2075-81. PubMed ID: 11371931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition.
    Gabellini C; De Luca T; Trisciuoglio D; Desideri M; Di Martile M; Passeri D; Candiloro A; Biffoni M; Rizzo MG; Orlandi A; Del Bufalo D
    Carcinogenesis; 2013 Nov; 34(11):2558-67. PubMed ID: 23836782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of vascular endothelial growth factor in the tissue specific in vivo growth of prostate cancer cells.
    Krupski T; Harding MA; Herce ME; Gulding KM; Stoler MH; Theodorescu D
    Growth Factors; 2001; 18(4):287-302. PubMed ID: 11519827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of angiogenesis by human glioma xenograft models that differentially express vascular endothelial growth factor.
    Ma J; Fei ZL; Klein-Szanto A; Gallo JM
    Clin Exp Metastasis; 1998 Aug; 16(6):559-68. PubMed ID: 9872603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate.
    Doll JA; Reiher FK; Crawford SE; Pins MR; Campbell SC; Bouck NP
    Prostate; 2001 Dec; 49(4):293-305. PubMed ID: 11746276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene.
    Belletti B; Ferraro P; Arra C; Baldassarre G; Bruni P; Staibano S; De Rosa G; Salvatore G; Fusco A; Persico MG; Viglietto G
    Oncogene; 1999 Aug; 18(34):4860-9. PubMed ID: 10490819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor.
    Balbay MD; Pettaway CA; Kuniyasu H; Inoue K; Ramirez E; Li E; Fidler IJ; Dinney CP
    Clin Cancer Res; 1999 Apr; 5(4):783-9. PubMed ID: 10213213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammalian target of rapamycin repression by 3,3'-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells.
    Kong D; Banerjee S; Huang W; Li Y; Wang Z; Kim HR; Sarkar FH
    Cancer Res; 2008 Mar; 68(6):1927-34. PubMed ID: 18339874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
    Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
    Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenically active vascular endothelial growth factor is over-expressed in malignant human and rat prostate carcinoma cells.
    Chen HJ; Treweeke AT; Ke YQ; West DC; Toh CH
    Br J Cancer; 2000 May; 82(10):1694-701. PubMed ID: 10817506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.